Vaxcyte, Inc. (PCVX)
61.16
+0.06
(+0.11%)
USD |
NASDAQ |
Aug 27, 16:00
61.18
+0.02
(+0.04%)
After-Hours: 20:00
Vaxcyte Total Assets (Quarterly) : 3.138B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.138B |
| March 31, 2026 | 3.348B |
| December 31, 2025 | 3.046B |
| September 30, 2025 | 3.172B |
| June 30, 2025 | 3.305B |
| March 31, 2025 | 3.378B |
| December 31, 2024 | 3.533B |
| September 30, 2024 | 3.560B |
| June 30, 2024 | 2.087B |
| March 31, 2024 | 2.091B |
| December 31, 2023 | 1.408B |
| September 30, 2023 | 1.496B |
| June 30, 2023 | 1.503B |
| March 31, 2023 | 1.008B |
| Date | Value |
|---|---|
| December 31, 2022 | 1.006B |
| September 30, 2022 | 412.06M |
| June 30, 2022 | 411.62M |
| March 31, 2022 | 402.72M |
| December 31, 2021 | 324.34M |
| September 30, 2021 | 354.07M |
| June 30, 2021 | 358.05M |
| March 31, 2021 | 382.35M |
| December 31, 2020 | 392.83M |
| September 30, 2020 | 403.82M |
| June 30, 2020 | 416.25M |
| March 31, 2020 | 162.53M |
| December 31, 2019 | 65.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 10.96B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 380.21M |
| Shareholders Equity (Quarterly) | 2.758B |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 5.724 |
| Net Debt Paydown Yield | -0.07% |